Most patients in the intensive care unit experience pain and anxiety, which are treated most commonly with an opioid or a benzodiazepine. These compounds are effective and have a well-established safety record. With the exception of associated respiratory depression, they have a relatively wide therapeutic window. New approaches and formulations for opioids and benzodiazepines are being used with continued success in the clinical setting.
|Original language||English (US)|
|Number of pages||25|
|Journal||Critical Care Clinics|
|State||Published - 1995|
ASJC Scopus subject areas
- Critical Care and Intensive Care Medicine